Biosynthesizing Psilocybin to Treat Mental Illness and Other Neurological Disorders with Evan Levine PsyBio Therapeutics TRANSCRIPT

https://traffic.libsyn.com/secure/empoweredpatient/Empowered_Patient_Podcast_Evan_Levine_PsyBio_TRANSCRIPT.pdf?dest-id=291449

Evan Levine, Co-Founder and CEO, PsyBio Therapeutics is pursuing a paradigm shift in the treatment of mental illness and other neurological disorders by using psychedelics and hallucinogenics. PsyBio biosynthesizes psilocybin and other psychoactive drugs from different plants  and fungi from genetically-modified bacteria. Under the influence of an anxiogenic molecule in a controlled setting, early clinical trials are showing a change in consciousness and rewiring of the brain to be able to address issues such as depression, anxiety, PTSD and substance abuse.

#Psychedelics #Psilocybin #Hallucinogenics #neuropsychiatricdisorders #tryptamines #PTSD #depression

PsyBioLife.com

Listen to the podcast here

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Related Post

NEWSLETTER

Sign up for Breaking News, Newsletter, Blog Posts and Special Deals from 1631 Digital and their media/marketing partners.

Subscribers agree to be contacted from 1631 Digital News and/or their media/marketing partners for breaking news alerts, newsletters and special media marketing offers via email, mail and/or texting communication.